GeneCentric launches PurIST test for pancreatic cancer through Tempus
PurIST is a new RNA- expression test for pancreatic cancer molecular subtyping to help inform and customise cancer…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Jun 23
PurIST is a new RNA- expression test for pancreatic cancer molecular subtyping to help inform and customise cancer…
31 May 23
Built with a deep neural network trained on thousands of images generated with various reconstruction methods, the Precision…
31 May 23
Route90 is a multi-centre clinical study, designed to assess the safety and efficacy of Eye90 microspheres in patients…
31 May 23
Minimal Residual Disease Monitoring for Patients with NPM1-mutated Acute Myeloid Leukemia
30 May 23
Guardant360 CDx is a comprehensive genomic profiling (CGP) blood test for patients with advanced solid cancers, and is…
30 May 23
VoxelSensors’ Switching Pixels Active Event Sensor is a novel category of ultra-low power and ultra-low latency 3D perception…
29 May 23
Claritas offers image enhancement and reconstruction software, iRAD and iPET, where iRAD can be used to enhance MRIs,…
29 May 23
The Eureka Clinical AI platform now has advanced clinical AI and deep learning technology to support clinicians for…
26 May 23
Tianlong is committed to expanding its presence in Thailand and working closely with local partners to provide excellent…
26 May 23
From 2024, Biosency will make its BVS3 technology available to healthcare professionals for integration into the BORA Care…